NRG Therapeutics Ltd logo

NRG Therapeutics Ltd

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

3

Funding Rounds

$37.2m

Money raised

Overview

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

Funding

Funding series

Funding Series Analysis

The company NRG Therapeutics Ltd has raised a total of $37.15m in funding over 3 rounds.

Key Insights:

  • NRG Therapeutics - Series A round, November 2022: $18.47m
  • NRG Therapeutics November 2022 Series A Funding Round: $18m
  • NRG Therapeutics August 2021 Seed Funding Round: $680k
NRG Therapeutics Ltd logo
NRG Therapeutics - Series A round, November 2022 $18.47m
NRG Therapeutics Ltd logo
NRG Therapeutics November 2022 Series A Funding Round $18m
NRG Therapeutics Ltd logo
NRG Therapeutics August 2021 Seed Funding Round $680k

Industries

NRG Therapeutics Ltd is active in the following industries: